Study of Oligo-Fucoidan in Advanced Hepatocellular Carcinoma (HCC)

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped After interim analysis, we planned to recruit 100 participants. However, due to COVID-19 challenges, statistician advised each group needs at least 30 samples (Gay, 1992). The sponsor and team decided to terminate the trial early for valid data.

Conditions

Advanced Hepatocellular Carcinoma

Interventions

DIETARY_SUPPLEMENT: Oligo Fucoidan
DIETARY_SUPPLEMENT: Placebo

Sponsor

Hi-Q Marine Biotech International, Ltd.